Stephen M Bloch
CIK 1400308 · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.22M
Companies
3
Total Filings
80
Lifetime Open-Market Net
-$307.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 735,665 | $66.91 | $49.22M | -$118.66M | 19 | 2026-07-24 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 618,479 | $0.55 | $340.2K | $5.00M | 5 | 2016-02-04 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,652,390 | $14.49 | $23.94M | -$193.34M | 50 | 2009-02-12 |
Recent Filings · Page 7 of 8
80 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-08-29 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,000 | -$83.1K | EDGAR |
| 2008-08-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −7,200 | -$98.3K | EDGAR |
| 2008-08-25 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,000 | -$81.3K | EDGAR |
| 2008-08-21 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,000 | -$81.8K | EDGAR |
| 2008-08-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,000 | -$94.9K | EDGAR |
| 2008-08-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −15,766 | -$271.6K | EDGAR |
| 2008-08-13 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −11,120 | -$187.0K | EDGAR |
| 2008-08-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −7,200 | -$119.7K | EDGAR |
| 2008-08-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −7,879 | -$124.9K | EDGAR |
| 2008-08-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −8,200 | -$125.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.